The future role of anti-tumour necrosis factor-α products in the treatment of Crohn's disease (vol 56, pg 299, 1998)

被引：0
作者：
van Hogezand, RA
Verspaget, HW
机构：
来源：
DRUGS | 1999年 / 57卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [21] The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn's Disease
    Greener, Tomer
    Boland, Karen
    Steinhart, A. Hillary
    Silverberg, Mark S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (04) : 458 - 464
  • [22] Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy
    Helbling, D
    Breitbach, TH
    Krause, M
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2002, 14 (12) : 1393 - 1395
  • [23] Role of Anti-Tumour Necrosis Factor Alpha Treatment in Patients With Autoimmune Liver Disease
    Vadamalayan, Babu
    Banur, Dinesh
    Samyn, Marianne
    Mieli-Vergani, Giorgina
    Hadzic, Nedim
    GASTROENTEROLOGY, 2013, 144 (05) : S447 - S447
  • [24] Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn's disease?
    Bhalme, Mahesh
    Sharma, Abhishek
    Keld, Richard
    Willert, Robert
    Campbell, Simon
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (05) : 543 - 549
  • [25] Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-α antibodies
    D'Auria, F
    Rovere-Querini, P
    Giazzon, M
    Ajello, P
    Baldissera, E
    Manfredi, AA
    Sabbadini, MG
    JOURNAL OF INTERNAL MEDICINE, 2004, 255 (03) : 409 - 418
  • [26] Regression of Sweet's syndrome associated with Crohn's disease after anti-tumour necrosis factor therapy
    Rahier, JF
    Lion, L
    Dewit, O
    Lambert, M
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2005, 68 (03) : 376 - 379
  • [27] Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behcet's disease
    Triolo, G
    Vadalà, M
    Accardo-Palumbo, A
    Ferrante, A
    Ciccia, F
    Giardina, E
    Citarrella, P
    Lodato, G
    Licata, G
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (06) : 560 - 561
  • [28] Acute paraplegia after the initiation of anti-tumour necrosis factor-a therapy for Crohn's disease
    Vadikolias, Konstantinos
    Kouklakis, George
    Heliopoulos, Ioannis
    Argyropoulou, Paraskevi
    Papanas, Nikolaos
    Tzilonidou, Maria
    Prassopoulos, Panos
    Piperidou, Haritomeni
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (02) : 159 - 162
  • [29] Gastrointestinal: Improvement of granuloma annulare with anti-tumour necrosis factor alpha therapy for Crohn's disease
    Fanning, Scott B.
    Chapman, Grace
    Yau, Yunki
    Leong, Rupert W. L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (01) : 215 - 215
  • [30] Cutaneous leishmaniasis associated with anti-tumour necrosis factor-α drugs: an emerging disease
    Marcoval, J.
    Penin, R. M.
    Sabe, N.
    Valenti-Medina, F.
    Bonfill-Orti, M.
    Martinez-Molina, L.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2017, 42 (03) : 331 - 334
12345